Your browser doesn't support javascript.
loading
Treating heparin-induced thrombocytopenia. the unconventional way!
Saudi Medical Journal. 2004; 25 (9): 1258-1260
en En | IMEMR | ID: emr-68846
Biblioteca responsable: EMRO
Heparin-induced thrombocytopenia HIT is a potentially devastating complication of heparin therapy. The severe form of HIT has been associated with both venous and arterial thrombosis manifested by myocardial infarction, cerebrovascular occlusion, skin necrosis or limb ischemia. Several agents are now available as alternatives to heparin in patients with suspected HIT, including the thrombin specific inhibitors lepirudin and argatroban as well as the low molecular weight heparinoid known as danaparoid. When lacking these agents, here we report the use of plasmapheresis to create an artificial state of anticoagulation; exchanging patient's plasma with albumin rather than fresh frozen plasma, to allow the safe introduction of warfarin
Asunto(s)
Buscar en Google
Índice: IMEMR Asunto principal: Trombocitopenia / Índice de Severidad de la Enfermedad / Trombina / Plasmaféresis Límite: Female / Humans Idioma: En Revista: Saudi Med. J. Año: 2004
Buscar en Google
Índice: IMEMR Asunto principal: Trombocitopenia / Índice de Severidad de la Enfermedad / Trombina / Plasmaféresis Límite: Female / Humans Idioma: En Revista: Saudi Med. J. Año: 2004